Good morning:
Before starting, I would like to clarify that I am using a slight computer assistance to improve my English and avoid continuous mistakes, the previous requested email was sent yesterday.
Regarding the points discussed, I will respond part by part organized by headline:
• Domain status: You are absolutely right. We have transferred the domains just as we discussed yesterday. As of today, at 08:00 (local time), the migration process is at 99.6%.
• Security and certificate issuance: The person who configured the domains has no relationship with those who sign and generate the certificates; they did not have access to that area. We have specific technicians who are the only ones authorized to sign each document. To do this, they use their own credentials, two-factor authentication, and a unique signature code.
• Coincidence in public certificates (0201 and 0203): That is correct. Regarding the public certificates, we can briefly clarify (since they are publicly accessible) that, indeed, both 0201 and 0203 were issued on October 13 and both indicate 10.8 mg / 98.8%. This is a mere coincidence; statistically it is totally possible for two different analyses to yield the same final value after rounding the figures.
• Transparency and measures adopted: A key point in our favor is that, being an honest and transparent company that does not alter data, the technician recorded the exact dose as it corresponded, without modifying it to make it look different. We had no knowledge of this situation until October 15, 2026, when a client who certifies with us informed us about it. After conducting an internal investigation, on Friday the 17th we sent a transparent notification to all our clients informing them of the situation. Likewise, we communicated to the company in question that, as of that same Friday the 17th, we could no longer continue receiving their products and we would proceed to the refund of those services already paid for that had not yet been delivered.
• Chromatogram policy and privacy: It should be noted that this client did not request the additional chromatography service. Although we have the raw data, our policy strictly forbids us from publishing anyone's private information; doing so would go against our ethical principles. Only the clients themselves can publish their reports via PDF or direct link and, if they wish, they can also make their raw data public. On our part, it would be unethical to publish a client's data to clarify a situation, as it would compromise the trust of the rest of our users. However, if the company in question requests them following the due process, they will be sent to them. We do not offer new analyses nor will we receive new samples; we deliver the work already done and we will provide them with their raw data if they so wish, a procedure that only they can manage from the email used for the orders and they can publish it themselves directly.
•Convalence management: Each certificate is signed by the responsible technician, who is the only one who can use their credentials so that their name appears on the document. Each certificate has a SHA-256 fingerprint (a 64-character code calculated from the exact PDF file). If a single character is changed, the code varies completely, so any edited copy will fail in our verification system. Furthermore, since October 20, 2026, that fingerprint is also anchored in the Bitcoin blockchain using OpenTimestamps, in a definitive and public block. On our verification page you can download the proof (.ots) and, by dragging it to opentimestamps along with the PDF, its authenticity is verified (in terms of creation date, I mean).
Logistics and delivery addresses: All our addresses correspond to package delivery points distributed throughout Alicante. Depending on the type of sample, it may arrive directly at our facilities or at a specialized center, all under the name of Convalence Labs. This process is random and it is the system itself that decides which address to expose and send the package to.
Facilities and photographic material: Regarding the equipment and other aspects, on our website you will find real photographs of our facilities. These can be easily verified, since most of them have a piece of paper stuck to the wall as an authenticity marker; it is public information. For reasons of confidentiality, we cannot send a photograph that includes your name, as this would establish a direct link that would generate the same regulatory risk, regardless of whether you act independently. Nonetheless, we will take more photographs of the different areas to show them publicly. For peptides, we use only HPLC-MS (or UHPLC-MS) with electrospray ionization (ESI). GC-MS is not suitable for peptides: they are large molecules, they do not evaporate, and they degrade with heat. Where GC-MS truly excels is with small, lipophilic molecules, such as anabolic steroids. After chemical derivatization, it separates their isomers and epimers with total clarity, and that is why it is our reference technique for this type of compounds. To separate the peptides, we work in reversed phase with a wide-pore C18 column, typically 300 Å, which adapts well to their size. Elution is performed with a linear gradient of water and acetonitrile, both with 0.1% formic acid. This makes the peaks sharper and improves ionization. Regarding calibration, we perform two, each with a different purpose. On one hand, we calibrate the spectrometer, specifically the precision of the mass axis (m/z), with commercial reference peptide mixtures. On the other hand, to know how much peptide is present, we compare the sample with a calibration curve made with a reference standard of the same peptide, of known purity and concentration. We confirm the mass on the intact molecule (MS1). With ESI, the peptide appears as several protonated ions, each with a different charge. Deconvolution software combines them and gives us the molecular mass, which we compare with the theoretical one. If it is also necessary to confirm the amino acid sequence, we use tandem mass spectrometry (MS/MS): we fragment the peptide by collision and analyze the resulting fragments, the b-type and y-type ions. That pattern functions as a fingerprint of its structure. (Response from Javier Montesinos, Lead Analytical Chemist)
Confidenciality of the NIF and invoicing: Regarding the NIF, there seems to be a misunderstanding about the functioning of the Spanish public administration. We have a duly registered NIF, but we keep it under strict confidentiality for reasons of operational security. In addition, a fundamental point is that, to issue an invoice with a NIF in Spain, it is mandatory to include the real data of the client (such as their identity document or passport), something that is unfeasible to manage in this sector of activity.
International regulatory differences: The legislation in force in Poland, the Czech Republic, and Hungary offers notable flexibility in this regard. In fact, in Poland it is possible to coordinate with the customs authorities to allow the entry of anabolic substances exclusively for analysis purposes. In Spain, on the contrary, to be able to legally withdraw a package it must be obligatorily declared as the real substance it is from the moment of shipment. After an inspection process that takes from 5 to 8 weeks, the authorities can release the package if it meets all specifications. In this sector, this procedure is extremely complex to perform, since most users prefer not to declare the real content for obvious reasons. We hope to find legal mechanisms that make it more viable in the future.
We perfectly understand the situation and take all comments as an opportunity for continuous improvement. We know that trust is not demanded, but built, and we are convinced that only time, perseverance, and our daily work will put us in the right place.
We are not the first to face doubts or skepticism. We remember how in its beginnings Analiza Bialek, when it focused on the analysis of raw materials and other substances, was also the object of strong questioning in the most important forum of the sector. However, their best response was daily work: they proved their value with rigor and professionalism. Today they are an unavoidable reference that certifies quality thanks to an excellent human team. Time and results gave them their place.
We thank you again for the opportunity to be able to answer openly. We hope you have a happy rest of the day.
The Convalence Labs Team